Antibacterial activity of cefamandole in vitro.

Cefamandole therapy in anaerobic infections. Antimicrob Agents Chemother (1979) 1.22

Pharmacokinetics and safety of cefamandole in infants and children. Antimicrob Agents Chemother (1978) 0.92

Pharmacology, Safety, and efficacy of cefamandole in childhood infections. Antimicrob Agents Chemother (1981) 0.78

Pharmacokinetics and safety of cefamandole in newborn infants. Antimicrob Agents Chemother (1979) 0.78

Evaluation of the Cathra inoculating device for susceptibility testing of methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother (1982) 0.75

Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med (1981) 5.44

A neighbor-interaction analysis of the hypochromism and spectra of DNA. J Mol Biol (1965) 3.24

Quantitative microassay in cell culture for enterotoxin of Shigella dysenteriae. J Infect Dis (1972) 2.40

Cefamandole: antimicrobial activity in vitro of a new cephalosporin. Antimicrob Agents Chemother (1975) 2.38

Determination of DNA composition and concentration by spectral analysis. J Mol Biol (1966) 2.12

Treatment of bacterial endocarditis with cephalothin. N Engl J Med (1968) 2.12

Expression of cloned hepatitis B virus DNA in human cell cultures. Proc Natl Acad Sci U S A (1980) 2.08

Bloodstream infections in the elderly. Am J Med (1989) 1.80

Pharmacological studies with cefamandole in human volunteers. Antimicrob Agents Chemother (1976) 1.68

Patient survival factors in paranasal sinus mucormycosis. Laryngoscope (1980) 1.68

Pharmacologic studies on tobramycin and comparison with gentamicin. J Clin Pharmacol New Drugs (1972) 1.66

Cephanone: in vitro antibacterial activity and pharmacology in normal human volunteers. Antimicrob Agents Chemother (1972) 1.64

Comparison of the antibacterial activities of sisomicin and gentamicin against gram-negative bacteria. Antimicrob Agents Chemother (1975) 1.62

Microbiological and pharmacological behavior of 7-chlorolincomycin. Appl Microbiol (1969) 1.60

Antimicrobial activity in vitro of netilmicin and comparison with sisomicin, gentamicin, and tobramycin. Antimicrob Agents Chemother (1977) 1.58

Renal aspergilloma: an unusual cause of infection in a patient with the acquired immunodeficiency syndrome. Am J Med (1992) 1.56

Tobramycin: in vitro antibacterial spectrum of a new aminoglycoside. J Clin Pharmacol New Drugs (1972) 1.55

Cephapirin: in vitro antibacterial spectrum. Appl Microbiol (1971) 1.50

Central nervous system infections in the elderly. Arch Intern Med (1989) 1.40

Cephapirin: pharmacology in normal human volunteers. J Clin Pharmacol New Drugs (1972) 1.36

Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics. Antimicrob Agents Chemother (1980) 1.35

Purification of naked intranuclear particles from human liver infected by hepatitis B virus. Proc Natl Acad Sci U S A (1974) 1.33

Infection due to Actinobacillus actinomycetemcomitans. Am J Clin Pathol (1971) 1.30

Pharmacology of cefazolin in human volunteers. J Clin Pharmacol (1973) 1.29

Pharmacokinetic study of netilmicin. Antimicrob Agents Chemother (1977) 1.28

Infections caused by microorganisms of the genus Erwinia. Ann Intern Med (1972) 1.27

D.N.A. polymerase in preparations containing Australia antigen. Lancet (1971) 1.27

Cephalexin: microbiological effects and pharmacologic parameters in man. Clin Pharmacol Ther (1969) 1.25

Endocarditis caused by Lactobacillus plantarum. Ann Intern Med (1973) 1.25

Syphilitic osteomyelitis with diffusely abnormal bone scan. Mt Sinai J Med (1979) 1.25

Pharmacologic studies with cefaclor, a new oral cephalosporin. J Clin Pharmacol (1978) 1.20

Pharmacokinetics of ampicillin-sulbactam in healthy elderly and young volunteers. Antimicrob Agents Chemother (1991) 1.19

Mycobacterial meningitis. Retrospective analysis from 1970 to 1983. Am J Med (1985) 1.19

Pseudomonas aeruginosa bacteremia in patients with AIDS. Clin Infect Dis (1994) 1.18

Clinical study of the use of the new aminoglycoside tobramycin for therapy of infections due to gram-negative bacteria. Antimicrob Agents Chemother (1974) 1.17

Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis (1996) 1.16

Clostridium difficile diarrhea induced by cancer chemotherapy. Arch Intern Med (1992) 1.15

Coxsackie virus myopericarditis. A microbiological and clinical review. Am J Cardiol (1974) 1.13

Antimicrobial activity of cefamandole against Salmonella typhi. Antimicrob Agents Chemother (1977) 1.09

Current patterns of infection in multiple myeloma. Am J Med (1972) 1.08

Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen. J Immunol (1981) 1.07

Sensitive indicators of inorganic mercury toxicity. Arch Environ Health (1986) 1.06

Integrator enzyme hypothesis for replication of hepatitis-B virus. Lancet (1975) 1.06

Comparative toxicities of third-generation cephalosporins. Am J Med (1985) 1.06

14 C-glucose oxidation in whole blood: a clinical assay for phagocyte dysfunction. Infect Immun (1972) 1.05

Bacteriological, pharmacological, and clinical studies of carbenicillin. Arch Intern Med (1970) 1.05

Pharmacokinetics of tobramycin in patients with stable renal impairment, patients undergoing peritoneal dialysis, and patients on chronic hemodialysis. Antimicrob Agents Chemother (1974) 1.05

Inhibitors of DNA polymerases of murine leukemia viruses: activity of ethidium bromide. Science (1971) 1.05

Pharmacokinetic parameters of sisomicin. Antimicrob Agents Chemother (1976) 1.03

Susceptibilities of gram-negative bacteria to combinations of antimicrobial agents in vitro. Antimicrob Agents Chemother (1975) 1.03

Fatal infections associated with Mycoplasma pneumoniae: discussion of three cases with necropsy findings. Mt Sinai J Med (1972) 1.00

DNA cloned from the ayw subtype of hepatitis B virus. J Med Virol (1980) 1.00

Concentration of clindamycin in human bone. Antimicrob Agents Chemother (1975) 0.99

Infection of human cells in culture with hepatitis B virus. Trans Assoc Am Physicians (1980) 0.97

Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis. Antimicrob Agents Chemother (1981) 0.97

Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers. Antimicrob Agents Chemother (1983) 0.97

Effect of cytosine arabinoside on the replication of the Moloney sarcoma virus in 3T3 cell cultures. J Natl Cancer Inst (1969) 0.96

Rhinocerebral mucormycosis: premortem diagnosis and therapy. Arch Intern Med (1979) 0.96

Biliary concentrations of piperacillin in patients undergoing cholecystectomy. Antimicrob Agents Chemother (1981) 0.96

Cephalexin: pharmacologic evaluation following oral and parenteral administration. J Clin Pharmacol (1973) 0.95

Hemophilus aphrophilus endocarditis: review of 23 cases. Am J Cardiol (1975) 0.93

Generalized Shwartzman reaction in man after a dog bite. Consumption coagulopathy, symmetrical peripheral gangrene, and renal cortical necrosis. Ann Intern Med (1970) 0.93

Inhibitors of viral nucleic acid transcriptases. Trans N Y Acad Sci (1971) 0.93

Oral and ambulatory therapy of Listeria bacteremia and meningitis with trimethoprim-sulfamethoxazole. Mt Sinai J Med (1983) 0.93

Clinical experience with cefotaxime in the treatment of patients with bacteremia. Rev Infect Dis (1983) 0.92

Effect of infection with Moloney sarcoma and leukemia viruses on nucleic acid synthesis in mouse cell cultures. J Natl Cancer Inst (1970) 0.92

Clinical patterns of osteomyelitis due to gram-negative bacteria. Arch Intern Med (1973) 0.91

Pulmonary toxoplasmosis in AIDS. Scand J Infect Dis (1987) 0.91